Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine
Clinical trial NCT00641017 · COMPLETED
Trial details
- NCT number
- NCT00641017
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2012-07-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.